1322
Anhua Liu et al. / Chinese Journal of Catalysis 39 (2018) 1320–1328
apparatus.
4‐hexyl‐1,3‐dioxolan‐2‐one (2g). 1H NMR (400 MHz, CDCl3):
δ = 4.83–4.66 (m, 1H), 4.51 (t, J = 8.0 Hz, 1H), 4.06 (t, J = 8.0 Hz,
1H), 1.81–1.63 (m, 2H), 1.46–1.29 (m, 8H), 0.88 (t, J = 6.4 Hz,
3H). 13C NMR (100 MHz, CDCl3): δ = 155.1, 77.1, 69.4, 33.9, 31.5,
28.8, 24.3, 22.5, and 14.0.
2.3. Catalyst preparation
In a Schlenk apparatus under dry nitrogen atmosphere,
sodium carbonate (18 mmol, 1.91 g), CC (3 mmol, 0.55 g), and
2,4,6‐trihydrazinyl‐1,3,5‐triazine (3 mmol, 0.51 g) was added to
1,4‐dioxane (20 mL) at room temperature. The above mixture
was stirred at room temperature for 6 h and then at 110 °C for
48 h. Afterwards, the light yellow precipitate was collected by
filtration and washed consecutively with dimethylformamide,
water, and methanol. Finally, the quantitatively yielded
product, designated HB‐CTP, was dried at 120 °C under
vacuum for 24 h. Elemental analysis results were as follows:
calculated value (%) N 63.78, C 33.42, H 2.80; found value (%)
N 60.75, C 27.89, H 2.65.
1
4‐(methoxymethyl)‐1,3‐dioxolan‐2‐one (2h). H NMR (400
MHz, CDCl3): δ = 4.81–4.77 (m, 1H), 4.48 (t, J = 8.4 Hz, 1H),
4.43–4.37 (m, 1H), 3.65–3.52 (m, 2H), 3.40 (s, 3H). 13C NMR
(100 MHz, CDCl3): δ = 155.1, 75.2, 71.5, 66.3, and 59.7.
4‐(isopropoxymethyl)‐1,3‐dioxolan‐2‐one (2i). 1H NMR
(400 MHz, CDCl3): δ = 4.80–4.77 (m, 1H), 4.48 (t, J = 8.4 Hz, 1H),
4.40–4.37 (m, 1H), 3.67–3.59 (m, 3H), 1.16 (d, J = 6.0 Hz, 6H).
13C NMR (100 MHz, CDCl3): δ = 155.2, 75.4, 72.8, 67.1, 66.4,
59.7, 21.9, and 21.8.
4‐(butoxymethyl)‐1,3‐dioxolan‐2‐one (2j). 1H NMR (400
MHz, CDCl3): δ = 4.82–4.76 (m, 1H), 4.47 (t, J = 8.4 Hz, 1H),
4.38–4.35 (m, 1H), 3.67–3.56 (m, 2H), 3.49 (d, J = 6.4 Hz, 2H),
1.57–1.50 (m, 2H), 1.38–1.29 (m, 2H), 0.89 (d, J = 7.6 Hz, 3H).
13C NMR (100 MHz, CDCl3): δ = 155.1, 75.2, 71.9, 69.7, 66.4,
31.6, 19.2, and 13.9.
2.4. General procedure for the cyclo‐addition reaction
A 15‐mL oven‐dried autoclave containing a magnetic stir
bar was charged with a corresponding epoxide (10 mmol),
HB‐CTP (50 mg), and TBAB (0.5 mmol, 0.16 g). The autoclave
was then purged with CO2 three times. The sealed autoclave
was pressurized to 2 MPa CO2 and continuously stirred at 80 °C
for 12 h. Afterwards, the autoclave was cooled to room
temperature, and the remaining CO2 was vented slowly. Yields
of the target products were determined by 1H NMR with
1,5‐dichloro‐2,4‐dinitrobenzene as an internal standard.
4‐((dodecyloxy)methyl)‐1,3‐dioxolan‐2‐one (2k). 1H NMR
(400 MHz, CDCl3): δ = 4.82–4.76 (m, 1H), 4.48 (t, J = 8.0 Hz, 1H),
4.40–4.36 (m, 1H), 3.67–3.58 (m, 2H), 3.49 (d, J = 6.8 Hz, 2H),
1.59–1.52 (m, 2H), 1.25 (m, 18H), 0.87 (d, J = 6.8 Hz, 3H). 13C
NMR (100 MHz, CDCl3): δ = 155.1, 75.2, 72.4, 69.8, 66.5, 32.0,
29.8, 29.8, 29.7, 29.7, 29.6, 29.5, 29.5, 26.1, 22.8, and 14.2.
4‐(phenoxymethyl)‐1,3‐dioxolan‐2‐one (2l). 1H NMR (400
MHz, CDCl3): δ = 7.33–7.29 (m, 2H), 7.02 (t, J = 7.4 Hz, 1H), 6.92
(d, J = 8.0 Hz, 2H), 5.06–5.00 (m, 1H), 4.62 (t, J = 8.4 Hz, 1H),
4.54 (dd, J = 8.5 and 5.9 Hz, 1H), 4.24 (dd, J = 10.5 and 4.4 Hz,
1H), 4.16 (dd, J = 10.5 and 3.6 Hz, 1H). 13C NMR (100 MHz,
CDCl3): δ = 157.9, 129.9, 122.2, 114.8, 74.2, 67.1, and 66.4.
4‐((benzyloxy)methyl)‐1,3‐dioxolan‐2‐one (2m). 1H NMR
(400 MHz, CDCl3): δ = 7.38–7.26 (m, 5H), 4.60–4.54 (m, 1H),
4.57 (q, J = 12.0 Hz, 2H), 4.47 (t, J = 8.4 Hz, 1H), 4.37 (dd, J = 8.3
and 6.0 Hz, 1H), 3.73–3.59 (m, 2H). 13C NMR (100 MHz, CDCl3):
δ = 155.0, 137.2, 128.4, 127.9, 127.6, 75.1, 73.5, 68.9, and 66.2.
4‐((allyloxy)methyl)‐1,3‐dioxolan‐2‐one (2n). 1H NMR (400
MHz, CDCl3): δ = 5.90–5.83 (m, 1H), 5.30–5.21 (m, 2H),
4.82–4.81 (m, 1H), 4.52–4.48 (m, 1H), 4.06–4.04 (m, 1H),
3.70–3.67 (m, 2H), 3.63–3.59 (m, 2H). 13C NMR (100 MHz,
CDCl3): δ = 155.0, 133.8, 118.1, 75.1, 72.7, 69.0, and 66.4.
2.5. Characterization data for cyclic carbonates
4‐Ethyl‐1,3‐dioxolan‐2‐one (2a). 1H NMR (400 MHz, CDCl3):
δ = 4.68–4.63 (m, 1H), 4.52 (t, J = 6.4 Hz, 1H), 4.07 (t, J = 6.0 Hz,
1H), 1.84–1.71 (m, 2H), 1.02 (t, J = 5.6 Hz, 3H). 13C NMR (100
MHz, CDCl3): δ = 155.2, 78.1, 69.1, 27.0, and 8.5.
4‐(chloromethyl)‐1,3‐dioxolan‐2‐one (2b). 1H NMR (400
MHz, CDCl3): δ = 4.97–4.94 (m, 1H), 4.59 (t, J = 8.7 Hz, 1H), 4.42
(dd, J = 8.8 and 6.3 Hz, 1H), 3.80–3.71 (m, 2H). 13C NMR (100
MHz, CDCl3): δ = 154.2, 74.3, 67.1, and 43.7.
4‐(bromomethyl)‐1,3‐dioxolan‐2‐one (2c). 1H NMR (400
MHz, CDCl3): δ = 4.98–4.92 (m, 1H), 4.59 (t, J = 8.8 Hz, 1H), 4.35
(dd, J = 8.9 and 5.9 Hz, 1H), 3.58–3.57 (m, 2H). 13C NMR (100
MHz, CDCl3): δ = 154.2, 74.1, 68.2, and 31.5.
1
4‐((prop‐2‐yn‐1‐yloxy)methyl)‐1,3‐dioxolan‐2‐one (2o). H
1
4‐(hydroxymethyl)‐1,3‐dioxolan‐2‐one (2d). H NMR (400
NMR (400 MHz, CDCl3): δ = 4.86–4.83 (m, 1H), 4.50 (t, J = 8.4
Hz, 1H), 4.40–4.36 (m, 1H), 4.27–4.16 (m, 2H), 3.79–3.69 (m,
2H), 2.48 (t, J = 2.4 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ =
155.0, 78.6, 75.7, 74.8, 68.5, 66.3, and 58.9.
4‐phenyl‐1,3‐dioxolan‐2‐one (2p). 1H NMR (400 MHz,
CDCl3): δ = 7.46–7.42 (m, 3H), 7.38–7.35 (m, 3H), 5.68 (t, J = 8.0
Hz, 1H), 4.80 (t, J = 8.4 Hz, 1H), 4.37–4.35 (m, 1H). 13C NMR
(100 MHz, CDCl3): δ = 154.9, 135.9, 129.9, 129.4, 126.0, 78.1,
and 71.3.
MHz, DMSO‐d6): δ = 5.25 (t, J = 4.4 Hz, 1H), 4.81–4.77 (m, 1H),
4.52–4.45 (m, 1H), 4.29–4.27 (m, 1H), 3.68–3.64 (m, 1H),
3.53–3.48 (m, 1H). 13C NMR (100 MHz, DMSO‐d6): δ = 155.2,
70.0, 65.9, and 60.6.
4‐methyl‐1,3‐dioxolan‐2‐one (2e). 1H NMR (400 MHz,
CDCl3): δ = 4.88–4.79 (m, 1H), 4.53 (t, J = 8.1 Hz, 1H), 4.00 (t, J =
8.3 Hz, 1H), 1.45 (d, J = 6.3 Hz, 3H). 13C NMR (100 MHz, CDCl3):
δ = 155.1, 73.6, 70.7, and 19.4.
4‐butyl‐1,3‐dioxolan‐2‐one (2f). 1H NMR (400 MHz, CDCl3):
δ = 4.73–4.66 (m, 1H), 4.52 (t, J = 8.1 Hz, 1H), 4.06 (t, J = 7.8 Hz,
1H), 1.81–1.67 (m, 2H), 1.40–1.37 (m, 4H), 0.91 (t, J = 6.9 Hz,
3H). 13C NMR (100 MHz, CDCl3): δ = 155.2, 69.5, 33.7, 26.5, 22.3,
and 13.9.
4‐(morpholinomethyl)‐1,3‐dioxolan‐2‐one (2q). 1H NMR
(400 MHz, CDCl3): δ = 4.82–4.75 (m, 1H), 4.48 (t, J = 8.3 Hz, 1H),
4.18 (t, J = 7.7 Hz, 1H), 3.61 (t, J = 4.3 Hz, 4H), 2.62 (d, J = 5.3 Hz,
2H), 2.48 (m, 4H). 13C NMR (100 MHz, CDCl3): δ = 154.7, 74.8,
67.6, 66.4, 69.8, and 54.0.